Find a Doctor

Marianna N. Koczywas

City Of Hope Medical Foundation
Oncology, Internal Medicine
Female
Practicing approx. 37 years

Bio


Marianna Koczywas is an Oncologist and an Internal Medicine specialist in Duarte, California. She has been an author on 74 peer reviewed articles and participated in 41 clinical trials in the past 15 years. She is licensed to treat patients in CA.

Contact

1500 E Duarte Rd
Duarte, CA 91010, US

Latest Advances


Latest Advance
Study
  • Condition: Clinically N2 Non-Small Cell Lung Cancer (NSCLC) Patients Undergoing Neoadjuvant Chemotherapy and Surgery
  • Journal: Lung cancer (Amsterdam, Netherlands)
  • Treatment Used: Optimal Adjuvant Therapy
  • Number of Patients: 1541
  • Published —
This study evaluated the impact of adjuvant chemotherapy (CT) and/or radiation (RT) in patients with clinically N2 (cN2) non-small cell lung cancer (NSCLC) undergoing neoadjuvant chemotherapy followed by surgery.
Latest Advance
Study
  • Condition: Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure
  • Journal: Clinical lung cancer
  • Treatment Used: Momelotinib combined with Trametinib
  • Number of Patients: 21
  • Published —
The study researched the effects of combining momelotinib with trametinib in treating metastatic, kirsten rat sarcoma viral oncogene homolog-mutated non-small cell lung cancer after platinum-based chemotherapy treatment failure.

Clinical Trials


Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Other, Drug, Biological
  • Participants: 1263
  • Start Date: June 3, 2020
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 10000
  • Start Date: January 28, 2019
LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 210
  • Start Date: September 28, 2018
A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of RMC-4630 Monotherapy in Adult Participants With Relapsed/Refractory Solid Tumors
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Biological
  • Participants: 66
  • Start Date: August 9, 2018
A Randomized Phase II Trial of Carboplatin-Paclitaxel With or Without Ramucirumab in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other, Drug, Biological
  • Participants: 8300
  • Start Date: August 18, 2014
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

All Publications
View All


Publication
Study
  • Journal: Journal of thoracic disease
  • Published —
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival.
Publication
Study
  • Journal: Journal of palliative medicine
  • Published —
A Palliative Care Intervention for Patients on Phase 1 Studies.

Contact

1500 E Duarte Rd
Duarte, CA 91010, US

Affiliations

  • City Of Hope Helford Clinical Research Hospital

Credentials

  • Licenses
    Internal Medicine in CA
  • Board Certifications
    Medical Oncology

Insurance

Contact them to find out if they accept your insurance plan.